Risk factors for vascular dementia and Alzheimer disease

被引：256

作者：

Gorelick, PB ^{[1
]}

机构：

[1] Univ Illinois, Coll Med, Dept Neurol & Rehabil, Chicago, IL 60612 USA

来源：

STROKE | 2004年 / 35卷 / 11期

关键词：

Alzheimer disease; cognitive disorders; risk factors;

D O I：

10.1161/01.STR.0000143318.70292.47

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Alzheimer disease and vascular cognitive impairment are important causes of cognitive decline in the elderly. It has now been shown that vascular risk factors have measurable negative effects on the brain and are associated with cognitive impairment. We review vascular factors that might be responsible to cognitive decline in Alzheimer disease and vascular cognitive impairment and the corresponding intervenvations that might prevent cognitive impairment as we age.

引用

页码：2620 / 2622

页数：3

共 36 条

[1] Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].

Aisen, PS ;

Schafer, KA ;

Grundman, M ;

Pfeiffer, E ;

Sano, M ;

Davis, KL ;

Farlow, MR ;

Jin, S ;

Thomas, RG ;

Thal, LJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826

[2] A randomized controlled trial of prednisone in Alzheimer's disease [J].

Aisen, PS ;

Davis, KL ;

Berg, JD ;

Schafer, K ;

Campbell, K ;

Thomas, RG ;

Weiner, MF ;

Farlow, MR ;

Sano, M ;

Grundman, M ;

Thal, LJ .

NEUROLOGY, 2000, 54 (03) :588-593

[3] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].

Anderson, GL ;

Limacher, M ;

Assaf, AR ;

Bassford, T ;

Beresford, SAA ;

Black, H ;

Bonds, D ;

Brunner, R ;

Brzyski, R ;

Caan, B ;

Chlebowski, R ;

Curb, D ;

Gass, M ;

Hays, J ;

Heiss, G ;

Hendrix, S ;

Howard, BV ;

Hsia, J ;

Hubbell, A ;

Jackson, R ;

Johnson, KC ;

Judd, H ;

Kotchen, JM ;

Kuller, L ;

LaCroix, AZ ;

Lane, D ;

Langer, RD ;

Lasser, N ;

Lewis, CE ;

Manson, J ;

Margolis, K ;

Ockene, J ;

O'Sullivan, MJ ;

Phillips, L ;

Prentice, RL ;

Ritenbaugh, C ;

Robbins, J ;

Rossouw, JE ;

Sarto, G ;

Stefanick, ML ;

Van Horn, L ;

Wactawski-Wende, J ;

Wallace, R ;

Wassertheil-Smoller, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712

[4] Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins [J].

Casserly, I ;

Topol, E .

LANCET, 2004, 363 (9415) :1139-1146

[5] Vascular dementia, a new beginning - Shifting focus from clinical phenotype to ischemic brain injury [J].

Chui, H .

NEUROLOGIC CLINICS, 2000, 18 (04) :951-+

[6] Framingham stroke risk profile and lowered cognitive performance [J].

Elias, MF ;

Sullivan, LM ;

D'Agostino, RB ;

Elias, PK ;

Beiser, A ;

Au, R ;

Seshadri, S ;

DeCarli, C ;

Wolf, PA .

STROKE, 2004, 35 (02) :404-409

[7] Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies [J].

Etminan, M ;

Gill, S ;

Samii, A .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7407) :128-+

[8]

EVANS GJ, 1988, EPIDEMIOLOGY AGING I, P36

[9] The prevention of dementia with antihypertensive treatment [J].

Forette, F ;

Seux, ML ;

Staessen, JA ;

Thijs, L ;

Babarskiene, MR ;

Babeanu, S ;

Bossini, A ;

Fagard, R ;

Gil-Extremera, B ;

Laks, T ;

Kobalava, Z ;

Sarti, C ;

Tuomilehto, J ;

Vanhanen, H ;

Webster, J ;

Yodfat, Y ;

Birkenhäger, WH .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (18) :2046-2052

[10] Prevention of vascular dementia [J].

Gorelick, PB ;

Erkinjuntti, T ;

Hofman, A ;

Rocca, WA ;

Skoog, I ;

Winblad, B .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1999, 13 :S131-S139

← 1 2 3 4 →